As OxyContin patent expires, US says generic versions must contain changes to thwart abuse

... it based its decision on medical studies of OxyContin, reports of abuse and misuse, public comments and petitions. Stamford, Connecticut-based Purdue said in a statement that the new labeling will provide "important information to health care ...



via Stamford Newswire http://www.winnipegfreepress.com/arts-and-life/life/health/as-oxycontin-patent-expires-fda-says-generic-versions-must-contain-changes-to-thwart-abuse-203282021.html